Accessibility Menu
 
Bausch Health Companies logo

Bausch Health Companies

(TSX) BHC

Current Price$7.82
Market Cap$2.85B
Since IPO (1994)+1,714%
5 Year-81%
1 Year+1%
1 Month+9%

Bausch Health Companies Financials at a Glance

Market Cap

$2.85B

Revenue (TTM)

$8.54B

Net Income (TTM)

$155.28M

EPS (TTM)

$0.56

P/E Ratio

13.63

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Price

$7.82

Volume

80,348

Open

$7.63

Previous Close

$7.62

Daily Range

$7.63 - $7.84

52-Week Range

$6.06 - $11.97

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bausch Health Companies

Industry

Pharmaceuticals

Employees

20,300

CEO

Thomas J. Appio

Headquarters

Laval, QC H7L 4A8, CA

BHC Financials

Key Financial Metrics (TTM)

Gross Margin

68%

Operating Margin

20%

Net Income Margin

2%

Return on Equity

0%

Return on Capital

9%

Return on Assets

1%

Earnings Yield

7.34%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.85B

Shares Outstanding

373.46M

Volume

80.35K

Avg. Volume

442.25K

Financials (TTM)

Gross Profit

$6.36B

Operating Income

$2.22B

EBITDA

$3.45B

Operating Cash Flow

$1.38B

Capital Expenditure

$403.95M

Free Cash Flow

$974.77M

Cash & ST Invst.

$1.32B

Total Debt

$21.21B

Bausch Health Companies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$2.84B

+10.9%

Gross Profit

$1.79B

-2.3%

Gross Margin

63.02%

N/A

Market Cap

$2.85B

N/A

Market Cap/Employee

$137.48K

N/A

Employees

20,700

N/A

Net Income

$113.72M

-222.3%

EBITDA

$1.02B

+20.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$19.88B

+2.7%

Accounts Receivable

$2.35B

+9.7%

Inventory

$1.63B

+1.9%

Long Term Debt

$20.91B

+10.4%

Short Term Debt

$296.46M

-88.9%

Return on Assets

0.59%

N/A

Return on Invested Capital

9.34%

N/A

Free Cash Flow

$402.53M

-18.5%

Operating Cash Flow

$495.92M

-17.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GTII.CNGreen Thumb Industries Inc.
$11.02-2.22%
TRUL.CNTrulieve Cannabis Corp.
$13.02+0.15%
CURA.TOCuraleaf Holdings, Inc.
$4.61-1.71%
CRON.TOCronos Group Inc.
$3.61-1.90%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.84+0.01%
POETPoet Technologies
$7.92-0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.07-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$60.23-0.04%

Questions About BHC

What is the current price of Bausch Health Companies?

Bausch Health Companies is trading at CA$7.82 per share.

What is the 52-week range for Bausch Health Companies?

Over the past 52 weeks, Bausch Health Companies has traded between CA$6.06 and CA$11.97.

How much debt does Bausch Health Companies have?

As of the most recent reporting period, Bausch Health Companies reported total debt of $28.89B.

How much cash does Bausch Health Companies have on hand?

Bausch Health Companies reported $1.82B in cash and cash equivalents in its most recent financial results.

What is Bausch Health Companies’s dividend yield?

Bausch Health Companies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.